Elsulfavirine (Elpida®): First Global Approval – a potential aid to the HIV epidemic in Russia

Elsulfavirine (Elpida®): First Global Approval – a potential aid to the HIV epidemic in Russia

The recent first global approval of elsulfavirine has been reviewed in detail in the First Global Approval report in Adis’ journal Drugs[1], based on the development milestones tracked in AdisInsight[2]. Continue reading “Elsulfavirine (Elpida®): First Global Approval – a potential aid to the HIV epidemic in Russia”